Xenetic

$2.12
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.01 (-0.46%) Today
-$0.05 (-2.30%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Xenetic and other stocks, options, and ETFs commission-free!

About XBIO

Xenetic Biosciences, Inc. Common Stock, also called Xenetic, is a biopharmaceutical company, which engages in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells.

CEO
Jeffrey F. Eisenberg
Employees
4
Headquarters
Framingham, Massachusetts
Founded
2011
Market Cap
18.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
182.57K
High Today
$2.18
Low Today
$2.11
Open Price
$2.18
Volume
35.06K
52 Week High
$5.85
52 Week Low
$0.73

XBIO Earnings

-$1.20
-$0.80
-$0.40
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 13, After Hours

You May Also Like

IPHA
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure